COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Also, Scripps does not provide COVID-19 tests for asymptomatic patients. See FAQs.

Elite iQ Laser Device for Treatment of Various Dermatologic Conditions

Trial ID:
IRB-21-7718
E. Victor Ross, M.D.
This study is evaluating the safety and effectiveness of the Elite iQ laser device for the treatment of hair removal, skin discoloration such as age spots, redness and spider veins, pigmented lesions, and pseudo-folliculitis barbae ('razor bumps') on multiple areas of the body. Study duration may last up to 15 months. Visits will be done in the Carmel Valley clinic.

Inclusion Criteria

Patients must:
  • Be a healthy adult 18 years of age or older
  • Have age spots, redness and spider veins, pigmented lesions, and pseudo-folliculitis barbae ('razor bumps')

Exclusion Criteria

Patients must not:
  • Have hypersensitivity to light
  • Have used tanning beds or tanning products, such as creams, lotions, and sprays within four weeks of study initiation
  • Be taking medication which is known to increase sensitivity to sunlight
  • Have a history of healing problems or history of keloid formation
  • Have an active localized or systemic infection in treatment area
  • Have a history of skin cancer
  • Have an autoimmune disease
  • Have a significant systemic illness in treatment area
  • Be receiving or have received gold therapy
  • Be currently enrolled in an investigational drug or device trial within the treatment area 6 months prior to entering this study

Additional Info

  • This is a post-market study of the Elite iQ device, which has been cleared for marketing by the FDA. This laser technology can target hair follicles, unwanted veins, pigmented lesions, and inflammation and bumps caused by shaving (razor bumps) without damaging the surrounding skin.

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org